In MDS, mutations in SF3B1 are associated with lower hemoglobin levels than other splice gene mutations and cluster with the presence of ringed sideroblasts and with DNMT3A mutations [1, 3, 34-38, 44-48]. This evidence concerns the gene DNMT3A and myelodysplastic syndrome.